- B2B
- Early StageStartup in initial stages
- Website
- Location
- Company size
- 1-10 people
- Total raised
- $1.4M
- Company type
- Molecular DiagnosticBiotech
- Markets
Aperiomics careers
From a single test, Aperiomics’ Absolute*NGS Pathogen Detection Service platform can simultaneously detect all pathogens, whether bacteria, virus, fungus, or parasite. This unique service uses an unbiased sequencing and genomic analysis approach, making it perfect for pathogen discovery, diagnosing difficult cases of unknown etiology, pathogen surveillance, and monitoring of natural animal populations, as well as routine pathogen detection. In simple terms, Aperiomics has combined genetic sequencing with computational power to give a rapid, highly specific, and accurate answer – even in cases where it’s unclear what the question should be. Applications for this new service are vast and include animal screening, agricultural testing, and human diagnostics. Aperiomics is currently working with groups in aquaculture and is seeking funding to expand service capabilities into industrial and clinical markets.
Aperiomics hasn't added any jobs yet
Get notified when Aperiomics posts new jobs.
Eduardo Castro-Nallar, PhD
CSO & Co-founder @Aperiomics
Crystal R Icenhour, PhD
Lead ~ Innovate ~ Commercialize | Founder @Aperiomics , @Phthisis Diagnostics • Studied at @Mayo Clinic, @Duke University , @University of Cincinnati
Keith Crandall, PhD
President & Co-founder @Aperiomics
Evan Johnson, PhD
CTO & Co-founder @Aperiomics
Total raised
$1.4M
Funded over
1 round
Latest round
Dec 2015
FIXD • Atlanta • $70k – $90k • No equity • yesterday
OneGlobe • Washington DC • 2 weeks ago
Karius • Redwood City • 3 weeks ago
bluebird bio • Somerville • $80k – $100k • 3 weeks ago
Van Metre Companies • Ashburn • 4 weeks ago